Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Microwave, HIFU), By Treatment (Laparoscopic Ablation, Percutaneous Ablation), By Application (Liver Cancer, Lung Cancer), And Segment Forecasts, 2024 - 2030

Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Microwave, HIFU), By Treatment (Laparoscopic Ablation, Percutaneous Ablation), By Application (Liver Cancer, Lung Cancer), And Segment Forecasts, 2024 - 2030


Tumor Ablation Market Growth & Trends

The global tumor ablation market size is anticipated to reach USD 4.0 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 13.5% from 2024 to 2030. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

Tumor Ablation Market Report Highlights
  • Radiofrequency ablation technology segment led the market with a share of more than 32.7% in 2023 owing to prominent application in solid tumor removal
  • Microwave ablation segment is expected to grow at the fastest CAGR of 14.27% from 2024 to 2030
  • The percutaneous ablation treatment segment held the largest revenue share of about 56.7% in 2023
  • Tumor ablation in lung cancer treatment is anticipated to witness the fastest growth from 2024 to 2030. Sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer
  • North America led the global market in 2023 owing to increased prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Treatment
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Treatment outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Tumor Ablation Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of cancer
3.2.1.2. Technological advancements in ablation devices
3.2.1.3. Increasing per capita income
3.2.1.4. Growing demand of minimally invasive surgeries.
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. Presence of alternative treatment options
3.3. Tumor Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Radiofrequency ablation
4.1.2. Microwave ablation
4.1.3. Cryoablation
4.1.4. Irreversible electroporation ablation
4.1.5. HIFU
4.1.6. Other ablation technologies
4.2. Technology Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Tumor Ablation Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Radiofrequency ablation
4.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.2. Microwave Ablation
4.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.3. Cryoablation
4.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.4. Irreversible electroporation ablation
4.5.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.5. HIFU
4.5.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.6. Other ablation technologies
4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Surgical ablation
5.1.2. Laparoscopic ablation
5.1.3. Percutaneous ablation
5.2. Treatment Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Tumor Ablation Market by Treatment Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Surgical Ablation
5.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.2. Laparoscopic Ablation
5.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.3. Percutaneous Ablation
5.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Kidney cancer
6.1.2. Liver cancer
6.1.3. Breast cancer
6.1.4. Lung cancer
6.1.5. Prostate cancer
6.1.6. Other cancer
6.2. Application Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Tumor Ablation Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Kidney cancer
6.5.1.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.2. Liver cancer
6.5.2.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.3. Breast cancer
6.5.3.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.4. Lung cancer
6.5.4.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.5. Prostate cancer
6.5.5.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.6. Other cancer
6.5.6.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.3. France
7.6.3.1. France Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. China Market Size Sstimates and Forecast, 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. India Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Analysis
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Boston Scientific Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. AngioDynamics
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bioventus Inc. (Misonix Inc.)
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. EDAP TMS
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Chongqing Haifu Medical Technology Co., Ltd
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Mermaid Medical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. HealthTronics, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. H.S. Hospital Service S.p.A.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings